Osheru Receives Funding for Ziplyft Device for Blepharoplasty

Osheru announced the successful completion of a $4.7 million funding round aimed at accelerating the development and commercialization of its Ziplyft device for blepharoplasty surgery. The funding round was oversubscribed and led by a consortium of investors including individuals, family offices, and notable figures such as Nike Co-Founder Phil Knight.

"This $4.7 million funding marks a pivotal moment for Osheru," said Dr. Patricia Buehler, CEO of Osheru. "It demonstrates the strong confidence in Ziplyft from both the medical community and investors, validating our vision to revolutionize blepharoplasty with cutting-edge technology."

Appointment of John Garland as Chief Commercial Officer

In addition to securing funding, Osheru appointed John Garland as Chief Commercial Officer. Mr. Garland, a seasoned executive in the ophthalmology industry with extensive experience in global operations and medical device innovation, expressed enthusiasm about his new role. "Joining Osheru to launch Ziplyft is an exciting opportunity," he remarked. "This innovative technology addresses key challenges in blepharoplasty, promising improved outcomes for patients and enhanced capabilities for surgeons."

Innovation in Blepharoplasty Surgery with Ziplyft

Blepharoplasty, which aims to rejuvenate the appearance of eyelids, has seen a significant rise in demand, particularly with the surge in video calls and selfies. Traditional methods have spurred interest in safer, less invasive alternatives like Ziplyft, positioning Osheru at the forefront of surgical innovation in this space.

The Ziplyft device, developed by Drs. Knute and Patricia Buehler leveraging their extensive surgical expertise, is designed to reduce recovery times and improve aesthetic outcomes compared to conventional procedures. "Ziplyft promises reduced downtime and enhanced aesthetic outcomes through its proprietary design," stated Dr. Buehler.

"We are enthusiastic about the potential of the technology to positively impact patient outcomes," commented Skip Rung, President of ONAMI, emphasizing the transformative potential of Ziplyft in the field of eyelid surgery.

Recognition and Future Prospects

Dr. Patricia Buehler, recognized for her contributions to ophthalmology, received acclaim earlier this year when Ziplyft won the Eyecelerator People’s Choice Award for its innovative advancements in blepharoplasty techniques. These accolades underscore Ziplyft’s potential to revolutionize multiple fields by offering minimally invasive alternatives to traditional skin removal procedures.

With commercialization slated for 2025, Osheru is poised to introduce Ziplyft as a game-changing solution for optimizing patient outcomes in eyelid surgery and other areas of excess skin removal.